Genelabs Technologies
Biotechnology ResearchView the employees at
Genelabs Technologies-
Judy Keller Director, Corporate Services at Genelabs Technologies
-
Redwood City, California, United States
-
Rising Star
Ann Arfsten SRAII at Genelabs Technologies Inc-
Redwood City, California, United States
-
Rising Star
Adam Villa Research Associate II at Genelabs Technologies-
Palo Alto, California, United States
-
Rising Star
Julie Yang Assoc. Director, Intellectual Property at Genelabs Technologies-
Rising Star
Andrea Berki Receptionist at Genelabs Technologies-
Redwood City, California, United States
-
Rising Star
Overview
Genelabs is a biopharmaceutical company focused on the discovery and development of novel compounds for infectious diseases. In addition to a late-stage drug candidate for Hepatitis E partnered with GlaxoSmithKline, the company is advancing multiple partnered and proprietary compounds designed to selectively inhibit replication of the hepatitis C virus, targeting the HCV viral proteins - NS5B polymerase, NS4B, and NS5A. In January 2009 Genelabs was bought by GlaxoSmithKline.
-